The Nasdaq Biotechnology Index rose 2.2%, reaching an intraday high since 2021Wallstreetcn·Oct 1, 2025 at 02:12 PMREGN-0.34%ARCT-4.02%
The Nasdaq Biotechnology Index rose by more than 2.4%. Among them, Editas Medicine increased by 34.72%, Arcturus Therapeutics Holdings Inc. rose by 29.01%, and Stoke Therapeutics climbed by 24.98%. In contrast, Pliant fell by 6.25%, Autolus Therapeutics dropped by 14.62%, and Zevra Therapeutics decreased by 19.81%Wallstreetcn·Aug 13, 2025 at 08:56 PMSTOK-1.61%ARCT-4.02%
